COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Elasomeran + imelasomeran is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t ...

Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying ...

Federal funding for COVID-19 vaccines will stop this year and the provinces and territories will be responsible for buying ...

Moderna's chief executive. He stressed however that the mRNA-1273.214 candidate – which combines the current SpikeVax booster with an Omicron-specific candidate – is the company's lead ...

Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...

The omicron relative now dominant in the U.S. is ... health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna. Years of earlier research — including Nobel-winning ...

COVID-19 has continued to claim lives at an average rate of about 900 deaths per week in the U.S. over the past year.